HeartWare International Inc  

(Public, NASDAQ:HTWR)   Watch this stock  
Find more results for htwr
-0.90 (-1.05%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 84.55 - 86.04
52 week 69.31 - 105.84
Open 85.66
Vol / Avg. 140,687.00/225,400.00
Mkt cap 1.44B
P/E     -
Div/yield     -
EPS -3.68
Shares 16.95M
Beta -0.16
Inst. own 99%
Jun 12, 2014
HeartWare International at Goldman Sachs Healthcare Conference Add to calendar
Jun 10, 2014
HeartWare International at William Blair & Company LLC Growth Stock Conference Add to calendar
May 13, 2014
HeartWare International at Bank of America Merrill Lynch Health Care Conference Add to calendar
Apr 28, 2014
Q1 2014 HeartWare International Earnings Release (Estimated) Add to calendar
Mar 11, 2014
HeartWare International at Barclays Healthcare Conference - Webcast
Mar 4, 2014
HeartWare International at Raymond James Financial Inc Institutional Investors Conference
Feb 27, 2014
Q4 2013 HeartWare International Earnings Release
Feb 27, 2014
Q4 2013 HeartWare International Earnings Conference Call - Webcast
Feb 13, 2014
HeartWare International at Leerink Swann Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -41.56% -28.52%
Operating margin -36.75% -22.87%
EBITD margin - -19.48%
Return on average assets -23.10% -18.64%
Return on average equity -45.29% -44.46%
Employees 396 -
CDP Score - -


United States - Map
+1-508-7390841 (Phone)
+1-508-7390948 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Heartware International, Inc. (HeartWare) develops and manufactures small implantable heart pumps, or ventricular assist devices, for the treatment of advanced heart failure. The HeartWare Ventricular Assist System (the HeartWare System), which includes a ventricular assist device (VAD), or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients in the advanced stage of heart failure. The core of the HeartWare System is a continuous flow blood pump, the HVAD Pump, which is a full-output device capable of pumping up to 10 liters of blood per minute. The HeartWare System is designed to be implanted adjacent to the heart, avoiding the abdominal surgery generally required to implant similar devices. In August 2012, it acquired World Heart Corporation. In December 2013, HeartWare International Inc acquired CircuLite, Inc.

Officers and directors

C. Raymond Larkin Jr Independent Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Douglas Evan Godshall President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Seth Loring Harrison M.D. Deputy Chairman of the Board
Age: 52
Bio & Compensation  - Reuters
Peter F. McAree Chief Financial Officer, Senior Vice President, Treasurer
Age: 48
Bio & Compensation  - Reuters
Jeffrey A. LaRose Executive Vice President, Chief Scientific Officer
Age: 51
Bio & Compensation  - Reuters
Lawrence Knopf Senior Vice President, General Counsel, Company Secretary
Age: 51
Bio & Compensation  - Reuters
James Schuermann Senior Vice President - Sales and Marketing
Age: 44
Bio & Compensation  - Reuters
Robert Yocher Senior Vice President - Regulatory & Quality Assurance
Age: 62
Bio & Compensation  - Reuters
David R. Hathaway M.D. Chief Medical Officer
Age: 65
Bio & Compensation  - Reuters
Timothy Joseph Barberich Independent Director
Age: 66
Bio & Compensation  - Reuters